8:48 AM
Jan 26, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Eureka raises $60M series D

Cancer company Eureka Therapeutics Inc. (Emeryville, Calif.) raised $60 million on Jan. 22 in a series D round led by existing investor Acorn Pacific Ventures. New investor GP Capital also participated, as did all existing major investors.


Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >